Variant Bio Launches New Partnership on Kidney Disease in South Africa
- Erin Burke (PhD)
Variant Bio is excited to announce the first research project in South Africa through a partnership with the African Research on Kidney Disease (ARK) Consortium
The ARK Consortium includes researchers from South Africa, Malawi, Uganda, and the London School of Hygiene and Tropical Medicine. The overall aim of this collaboration is to better understand kidney disease in Sub-Saharan African populations. More specifically, our research collaboration focuses on determining the burden of kidney disease, its causes, and how we might prevent kidney disease in our communities.
To help in this effort, Variant Bio is teaming up with a group of researchers at the University of the Witwatersrand in Johannesburg, South Africa. They are led by Dr. June Fabian, the principal investigator (PI) of the South African arm of ARK. June is a nephrologist (kidney doctor) at the Wits Donald Gordon Medical Centre.
Read the full story as it appears/or published on the Medium’s website.